Advertisement
 

doctorslounge.com

 
Powered by
Careerbuilder

 

                    Home  |  Forums  |  Humor  |  Advertising  |  Contact
   Ask a Doctor

   News via RSS

   Newsletter

   Pharmacy

   News

 

 Conferences


   CME

   Forum Archives

   Diseases

   Symptoms

   Labs

   Procedures

   Drugs

   Links
   Specialties

   Cardiology

   Dermatology

   Endocrinology

   Fertility

   Gastroenterology

   Gynecology

   Hematology

   Infections

   Nephrology

   Neurology

   Oncology

   Orthopedics

   Pediatrics

   Pharmacy

   Primary Care

   Psychiatry

   Pulmonology

   Rheumatology

   Surgery

   Urology

   Other Sections

   Membership

   Research Tools

   Medical Tutorials

   Medical Software

 

 Headlines:

 
 

Back to Pharmacology Articles

 Sunday, 16 February 2003 05:30 PM GMT

 
 

Ibuprofen may counteract the anti-platelet activities of aspirin leading to increased clot formation.

 
 

tellfrnd.gif (30x26 -- 1330 bytes)send to a friend
 
prntfrnd.gif (30x26 -- 1309 bytes)printer friendly version
 
 
  Related
 
 

Celebrex may not protect against ulcer
The Pharmacology Discussion Board

 
   
 
     

New research published this week in The Lancet medical journal suggests that ibuprofen may counteract the antiplatelet activities of aspirin.

Aspirin normally binds to an enzyme called cyclooxygenase in blood platelets, which stops them clumping together into vessel-clogging clots. Aspirin is recommended for most patients with cardiac ischemia or stroke. An unknown number of those also take ibuprofen for pain relief. The study suggests that ibuprofen may block aspirin from binding to cyclooxygenase. This compromises aspirin's ability to protect against the formations of clots and may eventually lead to death.

The study which was conducted by the Medicines Monitoring Unit of Britain's Medical Research Council checked the medical records of 7,107 heart patients who had been discharged from hospitals between 1989 and 1997 (8 years) with aspirin prescriptions and had survived at least one month after leaving the hospital.

They were divided into four groups according to their prescriptions. The first group included those on aspirin alone. The second were given aspirin and ibuprofen and the third group had aspirin with another pain killer, diclofenac. Ibuprofen and diclofenac both belong to a widely used class of pain relievers known as nonsteroidal anti-inflammatory drugs, or NSAIDs. The last group included those taking aspirin with any other NSAID, such as acetaminophen, which is in Tylenol.

It was found that heart patients taking both aspirin and ibuprofen were twice as likely to die during the study period as those who were taking aspirin alone or with other types of common pain relievers.

advertisement.gif (61x7 -- 0 bytes)
 

Are you a doctor or a nurse?

Do you want to join the Doctors Lounge online medical community?

Participate in editorial activities (publish, peer review, edit) and give a helping hand to the largest online community of patients.

Click on the link below to see the requirements:

Doctors Lounge Membership Application


In a preliminary study in 2001, FitzGerald showed that taking ibuprofen at night can block the anti-clotting effects of an aspirin swallowed the next morning. "The caution index for doctors has been raised appreciably," he says.

References
MacDonald, T. M. & Wei, L. Effect of ibuprofen on cardioprotective effect of aspirin. Lancet, 361, 573 - 574, (2003).
Catella-Lawson, F. et al. Cyclooxygenase inhibitors and the antiplatelet effects of aspirin. New England Journal of Medicine, 345, 1809 - 1817, (2001).

Article reviewed by:

Dr. Tamer Fouad, M.D.

 

 advertisement.gif (61x7 -- 0 bytes)

 

 



We subscribe to the HONcode principles of the HON Foundation. Click to verify.
We subscribe to the HONcode principles. Verify here

Privacy Statement | Terms & Conditions | Editorial Board | About us
Copyright 2001-2012 DoctorsLounge. All rights reserved.